Abstract | BACKGROUND: METHOD: Patients with a DSM-IV diagnosis of OCD and a Yale-Brown Obsessive Compulsive Scale (YBOCS) score >/= 16 were randomly assigned to receive venlafaxine, 225 to 350 mg/day (26 patients), or clomipramine, 150 to 225 mg/day (47 patients), for 12 weeks, with dosage adjustments according to tolerability and response to treatment. All patients were medication-free from at least 2 months prior to study enrollment. Efficacy measures were the YBOCS and the Clinical Global Impressions scale (CGI), which were completed at baseline and every 4 weeks. We defined responders as patients who had an improvement from baseline in YBOCS score of >/= 35% and a CGI score </= 2. An investigator who was blinded to patients' current medication administered rating scales independently. Moreover, patients were instructed not to reveal their current treatment to this investigator. RESULTS: Twenty-five patients in the venlafaxine group and 40 in the clomipramine group completed the 12-week trial. Responder rates at the end of the 12 weeks were 36% for venlafaxine (9/25) versus 50% for clomipramine (20/40) according to the visitwise analysis and 34.6% (9/26) for venlafaxine versus 42.6% (20/47) for clomipramine according to the last-observation-carried-forward analysis, with no statistically significant difference between the 2 drugs. Adverse experiences were reported by 61.5% of patients receiving venlafaxine (16/26) and by 91.5% of those receiving clomipramine (43/47). CONCLUSION: Our results indicate that venlafaxine might be as efficacious as clomipramine in the acute treatment of OCD, with fewer side effects.
|
Authors | Umberto Albert, Eugenio Aguglia, Giuseppe Maina, Filippo Bogetto |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 63
Issue 11
Pg. 1004-9
(Nov 2002)
ISSN: 0160-6689 [Print] United States |
PMID | 12444814
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Cyclohexanols
- Serotonin Uptake Inhibitors
- Venlafaxine Hydrochloride
- Clomipramine
|
Topics |
- Acute Disease
- Adult
- Ambulatory Care
- Clomipramine
(adverse effects, therapeutic use)
- Cyclohexanols
(adverse effects, therapeutic use)
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Male
- Obsessive-Compulsive Disorder
(diagnosis, drug therapy, psychology)
- Personality Assessment
- Selective Serotonin Reuptake Inhibitors
(adverse effects, therapeutic use)
- Single-Blind Method
- Treatment Outcome
- Venlafaxine Hydrochloride
|